Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo

  title={Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo},
  author={G. Cassano and C. Toni and A. Petracca and J. Deltito and G. Klerman},
  journal={European Neuropsychopharmacology},
  • G. Cassano, C. Toni, +2 authors G. Klerman
  • Published 1994
  • Medicine
  • European Neuropsychopharmacology
  • Side effects play a significant role in the selection of drugs to be used in panic disorder/agoraphobia whose polyphobic symptomatology often includes a suspiciousness about taking drugs and a fear of undesired side effects which may lead to the refusal of treatment. The safety, side effects and patients' acceptance of alprazolam and imipramine versus placebo were evaluated in 1168 subjects with panic disorder/agoraphobia who had been enrolled in the second phase of the Upjohn World Wide Panic… CONTINUE READING
    23 Citations
    Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation.
    • 126
    Antidepressants versus placebo for panic disorder in adults.
    • 16
    Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment
    • 6
    • Highly Influenced
    The role of alprazolam for the treatment of panic disorder in Australia
    • 22
    • Highly Influenced
    • PDF
    Antidepressants and benzodiazepines for panic disorder in adults.
    • 16
    Benzodiazepines versus placebo for panic disorder in adults.
    • 13


    Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    • 103
    Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    • 139
    Drug treatment of panic disorder.
    • R. Rosenberg
    • Chemistry, Medicine
    • Pharmacology & toxicology
    • 1993
    • 41
    High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
    • G. Tesar
    • Psychology, Medicine
    • The Journal of clinical psychiatry
    • 1990
    • 35
    Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    • 106
    Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
    • 83
    Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine.
    • 60
    Maintenance drug therapy of panic disorder.
    • 35
    • PDF